Department of Health Home A to Z Topics About the Department of Health Site Map Contact Us - Opens in a new window

Epidemiology Home

Health Topics (A-Z)

Related Links

Contact Us

   

Multistate Fungal Meningitis Outbreak

 

The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) are currently coordinating a multistate investigation of fungal meningitis among patients who received a steroid injection with a potentially contaminated product.  In several patients, the meningitis was found to be caused by a fungus that is common in the environment but rarely causes meningitis. This form of meningitis is not contagious. At this point, the original source of the outbreak has not been determined.  However, injectable steroid medication has been linked to the outbreak.

 

Several cases of illness have been reported in Florida to date and a response is being coordinated between local public health departments, the eight Florida facilities in receipt of the recalled product and the state Florida Department of Health. 

 

All infected patients identified thus far have received preservative-free (PF) methylprednisolone acetate (80mg/ml) from among the lots voluntarily recalled by the New England Compounding Center in Framingham, Massachusetts.  The products were recalled on on September 26, 2012. These lots are:

  • Methylprednisolone Acetate (PF) 80 mg/ml Injection, Lot #05212012@68, by use date (BUD) 11/17/2012

  • Methylprednisolone Acetate (PF) 80 mg/ml Injection, Lot #06292012@26, BUD 12/26/2012

  • Methylprednisolone Acetate (PF) 80 mg/ml Injection, Lot #08102012@51, BUD 2/6/2013

Map 1: Number of Outbreak-Associated Fungal Meningitis Cases by County
There are twenty-five cases, including five* deaths, among persons with linked to epidural steroid injections, as of December 6, 2012 at 1:21 PM (EST).

Total Number of Cases: 25

 

 

 

 

 

 

 

Count by County
Marion: 18
Escambia: 7

Florida Meningitis Cases

Map 2: Map of Florida Healthcare Facilities which Received Implicated Lots** of Methylprednisolone Acetate (PF) Recalled from New England Compounding Center on September 27, 2012

Florida Contaminated Facilities

*Deaths reported are from all causes among persons who meet the case definition and may not be directly attributed to a fungal infection.

**Lot #05212012@68, by use date (BUD) 11/17/2012; Lot #06292012@26, BUD 12/26/2012; Lot #08102012@51, BUD 2/6/2013


List of Florida Health Care Facility which Received Any Products Recalled from the New England Compounding Center

FLORIDA PAIN CLINIC 352-237-5906 OCALA FL
INTERVENTIONAL REHAB CENTER 850-484-8800 PENSACOLA FL
MARION PAIN MANAGEMENT CENTER 352-622-1845 OCALA FL
NORTH COUNTY SURGICENTER 561-626-6446 PALM BEACH GARDEN FL
ORLANDO CENTER FOR OUTPATIENT SURGERY 407-426-8331 ORLANDO FL
PAIN CONSULTANTS OF WEST FLORIDA 850-494-0000 PENSACOLA FL
SURGERY CENTER OF OCALA 352-237-5906 OCALA FL
SURGICAL PARK CENTER 305-271-9100 X226 MIAMI FL


Full list of all 257 Facilities that Received the NECC Products

Resources:

CDC Health Alert Network: Update (April 5, 2013)

Florida Health Alert Network: Surveillance Guidance for Physicians (November 21, 2012)

Florida Health Alert Network: Surveillance Guidance for Physicians (November 14, 2012)

CDC Health Alert Network (HAN): Contamination Identified in Additional Medical Products from New England Compounding Center (November 1, 2012)

CDC Health Alert Network (HAN): Voluntary Recall of All American Medical Products (November 1, 2012)

 

CDC Health Alert Network (HAN): Issuance of Guidance on Management of Asymptomatic Patients who Received Epidural or Paraspinal Injections with Contaminated Steroid Products (October 24, 2012)

 

Florida Health Alert Network: Guidance Document for Physicians (October 18, 2012)

 

CDC Health Alert Network (HAN): Multistate Outbreak of Fungal Meningitis and Joint Infections Associated with Contaminated Steroid Medications (October 17, 2012)

 

MMWR: Multistate Outbreak of Fungal Infection (October 12, 2012)

 

CDC Health Alert Network (HAN): Multistate Outbreak of Meningitis and Stroke Associated with Potentially Contaminated Steroid Medication (October 8, 2012)

 

Florida Health Alert Network: Guidance Document for Clinicians (October 7, 2012)

 

CDC Health Alert Network (HAN): Meningitis and Stroke Associated with Potentially Contaminated Product (October 4, 2012)

 

Interim Treatment Guidance for Central Nervous System and/or Parameningeal Infections Associated with Injection of Potentially Contaminated Steroid Products (CDC)

 

Frequently Asked Questions for Clinicians: Multistate Meningitis Outbreak Investigation (CDC)

 

Role of Antifungal Prophylaxis in Asymptomatic Patients (CDC)

 

Lumbar Puncture in Asymptomatic Patients (CDC)

 

CDC Website on Fungal Diseases

 

FDA Statement on Fungal Meningitis Outbreak

 

For up-to-date national information regarding the outbreak, visit the CDC Outbreak Investigation Page.

 

For a complete list of FDOH press releases, please visit the Florida Department of Health Online Newsroom.

 

For County Health Departments:

 

Florida Health Alert Network: Surveillance Guidance for CHDs (November 21, 2012)

 

Example Abnormal LP Results Data Collection Tool
 

Florida Health Alert Network: Surveillance Guidance for CHDs (November 7, 2012)

 

Florida Health Alert Network: Fungal Meningitis Reporting Guidance (October 30, 2012)

 

Meningitis Outbreak Following Epidural Steroid Injection CRF (October 29, 2012)

 

Florida Health Alert Network: Surveillance Guidance for CHDs (October 26, 2012)

 

CHD Specimen Submission Instructions for Cases Associated with Contaminated Injectable Product (October 25, 2012)

 

CDC Specimen Submission Form (October 12, 2012)

 

Case Definitions: Multi-state Outbreak Associated with Injection of Potentially Contaminated Steroid Product

 

 

This page was last modified on: 04/5/2013 03:19:06